SWK
50
4
LRCX
70
5
NRG
69
-6
RRC
65
3
AIG
57
-2
CMS
67
5
OMC
37
2
HES
47
2
SNA
55
2
SE
74
-5
CNX
44
2
WEC
65
3
CL
54
4
VRSK
63
-3
FOX
50
2
HSIC
53
3
ILMN
52
3
WU
14
2
PWR
72
-3
ADI
76
3
SWK
50
4
LRCX
70
5
NRG
69
-6
RRC
65
3
AIG
57
-2
CMS
67
5
OMC
37
2
HES
47
2
SNA
55
2
SE
74
-5
CNX
44
2
WEC
65
3
CL
54
4
VRSK
63
-3
FOX
50
2
HSIC
53
3
ILMN
52
3
WU
14
2
PWR
72
-3
ADI
76
3
Financhill
Back

China Pharma Holding 10K Form

Sell
26

CPHI
China Pharma Holding

Last Price:
$1.58
Seasonality Move:
-14.7%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CPHI News And Ratings

See the #1 stock for the next 7 days that we like better than CPHI

CPHI Financial Statistics

Sales & Book Value

Annual Sales: $4.5M
Cash Flow: $-138.8K
Price / Cash Flow: 12.76
Annual Sales: $2.14
Price / Book: 0.75

Profitability

EPS (TTM): -2.14000
Net Income (TTM): $-4.6M
Gross Margin: $-2M
Return on Equity: -61.79%
Return on Assets: -31.27%

China Pharma Holding Earnings Forecast

Key China Pharma Holding Financial Ratios

  • The Gross Profit Margin over the past 21 years for CPHI is -43.84%.
  • The Selling, General & Administrative Expenses for CPHI have been equal to 51.08% of Gross Profit Margin.
  • The Research & Development expenses have been 6.27% of Revenue.
  • The Net Earning history of CPHI is -104.58% of Total Revenues.
  • Per Share Earnings over the last 23 years have been positive in 11 years.

China Pharma Holding Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: CPHI
Website: chinapharmaholdings.com

Debt

Debt-to-Equity Ratio: 0.5
Current Ratio: 0.56
Quick Ratio: 0.15

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CPHI Technical Analysis vs Fundamental Analysis

Sell
26
China Pharma Holding (CPHI) is a Sell

Is China Pharma Holding a Buy or a Sell?